| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.6B | $26.7B | $28.3B | $36.6B | $26.0B | $17.8B | $20.4B | $15.6B |
| Cost of Revenue | — | $3.1B | $3.1B | $3.3B | $2.8B | $2.4B | $2.8B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.0B | $1.1B | $1.1B | $0.9B | $0.9B | $0.9B | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.4B | $3.1B | $4.7B | $13.3B | $2.3B | $-14.8B | $-1.0B | $4.1B |
| EPS (Basic) | $1.65 | $2.59 | $4.22 | $13.41 | $1.62 | $-17.06 | $-1.22 | $5.40 |
| EPS (Diluted) | $1.61 | $2.44 | $3.90 | $12.40 | $1.58 | $-17.06 | $-1.22 | $5.39 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $84.2B | $85.4B | $74.0B | $72.6B | $75.0B | $80.1B | $109.3B | $43.9B |
| Current Assets | $8.8B | $9.1B | $8.4B | $8.9B | $10.2B | $8.8B | $18.7B | $9.9B |
| Cash & Equivalents | $2.0B | $2.1B | $1.4B | $1.0B | $2.8B | $2.0B | $3.0B | $3.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $9.4B | $9.5B | $9.1B | $7.8B | $8.3B | $8.2B | $14.9B | $7.4B |
| Stockholders' Equity | $36.0B | $34.2B | $30.3B | $30.1B | $20.3B | $18.6B | $34.2B | $-0.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.5B | $11.4B | $12.3B | $16.8B | $10.4B | $4.0B | $7.4B | $7.7B |
| Investing Cash Flow | $-5.8B | $-14.6B | $-7.0B | $-4.9B | $-1.3B | $-0.8B | $-29.0B | $-3.2B |
| Capital Expenditures | $6.4B | $7.0B | $6.3B | $4.5B | $2.9B | $2.5B | $6.4B | $5.0B |
| Financing Cash Flow | $-4.8B | $3.8B | $-4.9B | $-13.7B | $-8.6B | $-4.5B | $22.2B | $-3.1B |